Index of /wp-content/uploads/2022/05/
| Name | Last Modified | Size |
|---|---|---|
 Parent Directory | ||
 Guidelines-for-Patient-Organisations-v-1.3.pdf | 2023-03-09 11:31 | 2182k |
| Plain-English-Summary-enzalutamide-nmCRPC.-HTA-ID-18056.pdf | 2023-03-09 11:31 | 470k |
| Ravulizumab-for-PNH-Technical-Summary-HTA-ID-19054.pdf | 2023-03-09 11:31 | 655k |
| Ravulizumab-fro-PNH-Plain-English-Summary-HTA-ID-19054.pdf | 2023-03-09 11:31 | 409k |
| Registration-form-2022.docx | 2023-03-09 11:31 | 26k |
| Technical-Summary-Enzalutamide-HTA-ID-18056.docx.pdf | 2023-03-09 11:31 | 642k |